Lymph Node Mapping in Gastric Cancer Surgery: Current Status and New Horizons.
Baris ZulfikarogluNuriye Ozlem KucukCigdem SoydalMehmet Mahir OzmenPublished in: Turkish journal of surgery (2020)
Gastric cancer (GC) remains one of the most important malignant diseases with significant geographical, ethnic, and socioeconomic differences in distribution. Sentinel lymph node (SLN) mapping is an accepted way to assess lymphatic spread in several solid tumors; however, the complexity of gastric lymphatic drainage may discourage use of this procedure, and the estimated accuracy rate is, in general, reasonably good. This study aimed at reviewing the current status of SLN mapping and navigation surgery in GC. SLN mapping should be limited to tumors clinically T1 and less than 4 cm in diameter. Combination SLN mapping with radioactive colloid and blue dye is used as the standard. Despite its notable limitations, SLN mapping and SLN navigation surgery present a novelty individualizing the extent of lymphadenectomy.
Keyphrases
- sentinel lymph node
- lymph node
- high resolution
- minimally invasive
- neoadjuvant chemotherapy
- early stage
- current status
- high density
- coronary artery bypass
- surgical site infection
- squamous cell carcinoma
- radiation therapy
- mass spectrometry
- coronary artery disease
- percutaneous coronary intervention
- ultrasound guided
- robot assisted
- tandem mass spectrometry
- simultaneous determination